INIMMUNE CORP has a total of 12 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BOYEN THERAPEUTICS INC, SERRA VINCENT and HEFEI COSOURCE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Ettenger George | 8 |
#2 | Khalaf Juhienah | 8 |
#3 | Ryter Kendal T | 8 |
#4 | Bazin-Lee Helene | 7 |
#5 | Secor Patrick | 2 |
#6 | Parks William | 2 |
#7 | Bollyky Paul L | 2 |
#8 | George Ettenger | 1 |
#9 | Kendal T Ryter | 1 |
#10 | Juhienah Khalaf | 1 |
Publication | Filing date | Title |
---|---|---|
US2021023106A1 | Toll-like receptor ligands |